Proto Labs (PRLB)
(Delayed Data from NYSE)
$31.37 USD
-0.05 (-0.16%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $31.40 +0.03 (0.10%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth B Momentum B VGM
Cash flow Statements
Fiscal Year End for Proto Labs, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 17.22 | -103.46 | 33.37 | 50.87 | 63.66 |
Depreciation/Amortization & Depletion | 37.53 | 39.43 | 40.49 | 33.01 | 30.87 |
Net Change from Assets/Liabilities | 5.58 | -1.60 | -25.64 | 1.18 | 4.25 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 12.95 | 127.72 | 7.02 | 21.91 | 17.28 |
Net Cash From Operating Activities | 73.27 | 62.08 | 55.24 | 106.97 | 116.05 |
Property & Equipment | -27.42 | -17.58 | -34.21 | -47.01 | -62.23 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | -127.41 | 0.00 | 0.00 |
Investments | 22.87 | -25.51 | 66.96 | -48.46 | 17.93 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -4.55 | -43.09 | -94.66 | -95.47 | -44.30 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | -41.55 | -27.39 | -21.64 | -10.57 | -31.62 |
Issuance (Repayment) of Debt | -0.31 | -0.53 | -0.55 | -0.15 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | -41.86 | -27.92 | -22.20 | -10.73 | -31.62 |
Effect of Exchange Rate Changes | 0.37 | -0.44 | -0.05 | 1.61 | 0.05 |
Net Change In Cash & Equivalents | 27.23 | -9.37 | -61.67 | 2.38 | 40.18 |
Cash at Beginning of Period | 56.56 | 65.93 | 127.60 | 125.23 | 85.05 |
Cash at End of Period | 83.79 | 56.56 | 65.93 | 127.60 | 125.23 |
Diluted Net EPS | 0.66 | -3.77 | 1.21 | 1.89 | 2.35 |
Fiscal Year End for Proto Labs, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | 17.22 | 10.23 | 2.28 | 2.66 |
Depreciation/Amortization & Depletion | NA | 37.53 | 28.21 | 18.88 | 9.39 |
Net Change from Assets/Liabilities | NA | 5.58 | 10.60 | 4.68 | 9.69 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 12.95 | 7.00 | 6.03 | 0.84 |
Net Cash From Operating Activities | NA | 73.27 | 56.05 | 31.87 | 22.58 |
Property & Equipment | NA | -27.42 | -9.24 | -6.21 | -3.25 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 22.87 | 19.12 | 14.02 | 7.63 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | -4.55 | 9.87 | 7.81 | 4.38 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | -41.55 | -38.50 | -29.50 | -21.52 |
Issuance (Repayment) of Debt | NA | -0.31 | -0.23 | -0.16 | -0.08 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | NA | -41.86 | -38.74 | -29.67 | -21.60 |
Effect of Exchange Rate Changes | NA | 0.37 | -0.24 | -0.08 | 0.13 |
Net Change In Cash & Equivalents | NA | 27.23 | 26.94 | 9.94 | 5.49 |
Cash at Beginning of Period | NA | 56.56 | 56.56 | 56.56 | 56.56 |
Cash at End of Period | NA | 83.79 | 83.50 | 66.49 | 62.05 |
Diluted Net EPS | NA | 0.26 | 0.31 | -0.01 | 0.10 |